We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama... Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India. Show more
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference PR Newswire SAN FRANCISCO, March 22, 2024 SAN FRANCISCO, March 22, 2024...
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata PR Newswire SAN FRANCISCO, March 5, 2024...
Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results PR Newswire SAN FRANCISCO, March 4, 2024 SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq:...
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX PR Newswire SAN FRANCISCO, March 4, 2024 SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq:...
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference PR Newswire SAN FRANCISCO, Feb. 27, 2024 SAN FRANCISCO, Feb. 27, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.33 | 1.43 | 1.2 | 1955568 | 1.30660133 | CS |
4 | 0.4 | 43.0107526882 | 0.93 | 1.75 | 0.9 | 3854039 | 1.36023793 | CS |
12 | 0.7731 | 138.822050637 | 0.5569 | 1.75 | 0.532 | 2665738 | 1.07490156 | CS |
26 | 0.8429 | 173.044549374 | 0.4871 | 1.75 | 0.4126 | 1905318 | 0.87465757 | CS |
52 | 0.5538 | 71.3475908271 | 0.7762 | 1.75 | 0.4126 | 3310044 | 0.81235207 | CS |
156 | -18.32 | -93.2315521628 | 19.65 | 20.66 | 0.4126 | 2737603 | 3.91073163 | CS |
260 | -30.51 | -95.8228643216 | 31.84 | 36.85 | 0.4126 | 2327421 | 9.12234643 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions